Cat. No. | Product Name | CAS No. | Purity | Chemical Structure |
---|---|---|---|---|
TP1878 | PACAP (1-38), human, ovine, rat
腺苷酸环化酶激活肽-38(抗原)
|
137061-48-4 | 98% |
|
PACAP (1-38), human, ovine, rat (Pituitary Adenylate Cyclase Activating Polypeptide 38) 是含有 38 个氨基酸残基的神经肽。它能够结合 PACAP I 型受体(IC50:4 nM)、PACAP II 型受体 VIP1(IC50:2 n... | ||||
T36428 | PACAP-related Peptide (human) (trifluoroacetate salt)
PACAP-related Peptide (human) (trifluoroacetate salt)
|
98% |
|
|
PACAP-related peptide (PRP) is an endogenous 29-amino acid peptide that belongs to the secretin/glucagon superfamily of peptides, which includes secretin , gluca... | ||||
T36427 | PACAP (6-27) (human, chicken, mouse, ovine, porcine, rat) (trifluoroacetate salt)
PACAP (6-27) (human, chicken, mouse, ovine, porcine, rat) (trifluoroacetate salt)
|
98% |
|
|
Pituitary adenylate cyclase-activating peptide (PACAP) (6-27) is a PACAP receptor antagonist with IC50 values of 1,500, 600, and 300 nM, respectively, for rat PA... | ||||
T37435 | PACAP-related Peptide (rat) (trifluoroacetate salt)
PACAP-related Peptide (rat) (trifluoroacetate salt)
|
98% |
|
|
PACAP-related peptide (PRP) is an endogenous 29-amino acid peptide that belongs to the secretin/glucagon superfamily of peptides, which includes secretin , gluca... | ||||
TP1722L | PACAP (6-38), human, ovine, rat acetate
化合物TP1722L
|
99.84% |
|
|
PACAP (6-38), human, ovine, rat acetate 是一种有效的 PACAP 受体拮抗剂。PACAP (6-38) 作用于 PACAP I 型受体,PACAP II 型受体 VIP1 和 PACAP II 型受体 VIP2,IC50 分别为 30 nM,600 nM 和 40 nM。 | ||||
T78105 | PAC1R antagonist 1
PAC1 拮抗剂1
|
2305204-24-2 | 98.43% |
|
PAC1R antagonist 1为一种具有口服活性的 PAC1 受体拮抗剂,可抑制由垂体腺苷酸环化酶激活多肽(PACAP)及神经损伤所诱导的异常性疼痛,可用于研究肿瘤和与免疫相关的疾病。 | ||||
TP1070L | PACAP (1-27), human, ovine, rat acetate
化合物TP1070L
|
TP1070L | 98% |
|
PACAP (1-27), human, ovine, rat acetate (PACAP 1-27 acetate)(127317-03-7 free base) 是一种新的神经肽,最初从牛下丘脑中分离出来,也存在于人和大鼠中。 | ||||
T41005 | PA-8
化合物PA-8
|
878437-15-1 | 97.64% |
|
PA-8是一种小分子的的 PACAP I 型(PAC1)受体拮抗剂,有 选择性、有效性和口服活性。PA-8抑制PACAP 诱导的CREB 在PAC1-受体上的磷酸化,但对VPAC11或VPAC2受体无抑制作用。PA-8也抑制pacap 诱导的体外cAMP 水平升高(IC50 = 2 nM)和体内鞘内注射后pacap 诱导... | ||||
TP1618L | PACAP-38 (31-38), human, mouse, rat acetate
化合物PACAP-38 (31-38), human, mouse, rat acetate
|
98% |
|
|
PACAP-38 (31-38), human, mouse, rat acetate 是 PAC1 受体的激活剂。PACAP-38 (31-38), human, mouse, rat acetate 对交感神经元 NPY 和儿茶酚胺的产生具有强效、有效和持续的刺激作用,可用于神经营养和神经保护研究。 | ||||
TP1878L | PACAP 1-38 acetate
化合物PACAP 1-38 acetate
|
98% |
|
|
PACAP 1-38 acetate 是一种垂体腺苷酸环化酶激活多肽 (PACAP) 类似物。它与 PACAP I 型受体 (IC50 = 4 nM) 和 PACAP II 型 VIP2 受体 (IC50 = 1 nM) 结合,但不与 PACAP II 型 VIP1 受体结合。 |